Novel Laboratories Recalls Famotidine Oral Suspension Due to Impurity Failure
Novel Laboratories is recalling 25,776 containers of Famotidine Oral Suspension because the product failed an impurity specification. The recall is classified as FDA Class III.
- Product
- FAMOTIDINE — FAMOTIDINE (FAMOTIDINE)
- Category
- Drug
- Distribution
- Distributed nationwide